GEVHER NESIBE 4. ULUSLAR ARASI SAGLIK BILIMLERI KONGRESI, Ankara, Türkiye, 23 - 24 Kasım 2019, ss.229-233
Autism spectrum disorder (ASD); It is an extremely heterogeneous
neurodevelopmental disorder that occurs in early childhood, characterized by
lack of social interaction and communication, sensory differences, limited
interests, and stereotypical repetitive rigid behavior patterns.
The estimated global prevalence of autism spectrum disorder (ASD) is
approximately 1.0%.
Although the number of cases of Autism Spectrum Disorders (ASD) diagnosed
during the last four decades has increased significantly, there is still
considerable debate about the underlying pathophysiology of ASD.
The aim of this retrospective study was to evaluate the biochemical blood
parameters of children with autism.
The study included 30 children with autism aged between 10 and 18 years and
30 healthy children as a control group. The autism group was selected from the children with
autism diagnosis in the Department of Pediatric Neurology at Gazi University
Faculty of Medicine between 2018-2019 and the control group was selected from
the Children's Health Unit. In two groups, routine biochemical parameters were
evaluated retrospectively.
According to the study, the ratio of boys to girls was 1,5 in children with
autism and 0,87 in the control group. Although vitamin 25-OHD levels were low in both autism
and control groups, the difference was statistically significant p = 0.025. and
vitamin 25-OHD levels in the autism group were lower than in the control group
(p<0,05) . Vitamin D deficiency has recently been considered a potential environmental
risk factor for ASD. Vitamin D is potent neurosteroid, which mediates numerous
actions in several body tissues including brain. The difference between ALT levels of autism and control
group was also statistically significant, p = 0,049 (p <0,05).
We believe that randomized controlled trials using adequate doses of
vitamin D3 are necessary in children with autism, and that further studies on
nutritional disorders and behavioral problems, metabolic differences, and
biomarkers are necessary.